CARLSBAD, Calif.--(BUSINESS WIRE)--Helixis, Inc., an early-stage company focused on the development of low-cost, fast and accurate molecular diagnostic products and research instruments, today announced the participation of Advanced Technology Ventures (ATV) in the Company’s $10 million Series A round completed in late August, joining Domain Associates and Okapi Venture Capital.
